Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
2.
Genet Test Mol Biomarkers ; 28(2): 59-64, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-38416664

RESUMEN

Background: Vitamin D receptor (VDR) is a nuclear hormone receptor widely expressed in the substantia nigra. Its association with an increased risk of Parkinson's disease (PD) is based on vitamin D deficiency and/or different polymorphisms in its gene receptor. This fact has been demonstrated by several case-control studies. Materials and Methods: Consequently, we investigated the association between VDR ApaI, BsmI, FokI, and TaqI gene polymorphisms and PD in a Spanish cohort that included 54 cases and 17 healthy controls. The detection of single nucleotide polymorphisms (SNPs) was performed using a polymerase chain reaction-restriction fragment length polymorphism. Results: Our data indicate that the SNPs were not associated with the age of onset of PD, nor with the occurrence of motor symptoms. However, only BsmI polymorphism was significantly associated with PD in this Spanish cohort. In fact, BsmI genotype was five times higher among PD patients than among controls, and the A allele was considered as a genetic risk for PD. Additionally, the combination of FokI and BsmI polymorphisms was significantly associated with PD and could represent a risk factor. Conclusion: We conclude that ApaI, TaqI, and FokI polymorphisms were not associated with PD, but BsmI could be a risk factor for PD in this randomized population.


Asunto(s)
Imidoésteres , Enfermedad de Parkinson , Receptores de Calcitriol , Humanos , Estudios de Casos y Controles , Predisposición Genética a la Enfermedad/genética , Genotipo , Enfermedad de Parkinson/genética , Polimorfismo de Nucleótido Simple/genética , Receptores de Calcitriol/genética , Vitamina D
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA